Clinical Trial Update: Does the Fecal Microbiome Influence Rotarix Immunogenicity

View source ↗

Summary

A completed clinical trial explored whether the composition of the fecal microbiome affects the immunogenicity of the Rotarix rotavirus vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infections

Drugs mentioned

• Rotarix (Rotavirus vaccine (live attenuated))

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Rotavirus Infections, Reaction - Vaccine Nos | Status: COMPLETED